Jenburkt Pharmaceuticals informs about disclosure

22 Dec 2022 Evaluate

Jenburkt Pharmaceuticals has informed that the exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Mahesh H Bhuta, Jagruti Ketan Bhuta, Riddhi Haresh Shroff, Prakash H Bhuta & PACs.

The above information is a part of company’s filings submitted to BSE.

Jenburkt Pharma Share Price

1009.85 -8.15 (-0.80%)
09-Apr-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1652.10
Dr. Reddys Lab 1095.15
Cipla 1416.30
Lupin 1921.30
Zydus Lifesciences 844.60
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Please wait your portfolio is updating...